Royal Bank of Canada’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Royal Bank of Canada’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-4,500	Closed	-$73K	–	6312
2013 Q2	$73K	Buy	+4,500	New	+$139K	﹤0.01%	4470

Other funds holding INFI

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Royal Bank of Canada's INFI Position: Q3 2023 in Review

Royal Bank of Canada sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 959 shares.

Royal Bank of Canada first reported a position in INFI in Q2 2013 and held it in 37 quarters. The position peaked at $685K in Q4 2014. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

Royal Bank of Canada reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Royal Bank of Canada sold 959 Infinity Pharmaceuticals, Inc. shares in Q3 2023.
Royal Bank of Canada first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 37 quarters.
Royal Bank of Canada's Infinity Pharmaceuticals, Inc. position peaked at $685K in Q4 2014.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.